Profile data is unavailable for this security.
About the company
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
- Revenue in SEK (TTM)89.71m
- Net income in SEK-120.62m
- Incorporated1999
- Employees50.00
- LocationSenzime AB (publ)Verkstadsgatan 8, hus 1UPPSALA 753 23SwedenSWE
- Phone+46 18515640
- Fax+46 18515630
- Websitehttps://senzime.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mentice AB | 274.49m | -43.31m | 383.92m | 121.00 | -- | 3.05 | -- | 1.40 | -1.68 | -1.68 | 10.52 | 4.48 | 0.9663 | 1.60 | 3.94 | 2,095,328.00 | -15.25 | -6.64 | -31.60 | -11.91 | 90.40 | 84.80 | -15.78 | -8.53 | 0.845 | -30.10 | 0.116 | -- | 6.11 | 14.22 | -553.89 | -- | 32.86 | -- |
| Ortoma AB | 77.19m | -7.52m | 456.91m | 10.00 | -- | 2.90 | 87.50 | 5.92 | -0.2027 | -0.2027 | 2.08 | 4.45 | 0.4243 | 3.95 | 39.13 | 7,530,537.00 | -4.13 | -9.37 | -4.45 | -10.43 | 41.26 | 158.24 | -9.74 | -78.90 | 3.02 | -- | 0.00 | -- | 28.77 | -- | 46.83 | -- | -0.5751 | -- |
| Q linea AB | 11.10m | -182.48m | 462.55m | 83.00 | -- | 1.37 | -- | 41.68 | -35.87 | -35.87 | 1.31 | 17.84 | 0.0429 | 0.4006 | 2.90 | -- | -70.50 | -76.00 | -101.81 | -93.84 | -15.26 | -145.47 | -1,644.30 | -2,820.51 | 10.04 | -30.48 | 0.017 | -- | 369.86 | 114.75 | 15.86 | -- | -34.47 | -- |
| Bactiguard Holding AB | 228.77m | -7.84m | 495.15m | 153.00 | -- | 1.77 | 12.62 | 2.16 | -0.2238 | -0.2238 | 6.53 | 8.99 | 0.381 | 3.44 | 6.91 | 1,495,216.00 | -1.31 | -8.02 | -1.86 | -10.13 | 63.78 | 48.56 | -3.43 | -25.10 | 1.38 | -0.3387 | 0.3410 | -- | -12.64 | 4.22 | 73.69 | -- | -17.92 | -- |
| Modulight Oyj | 71.90m | -49.03m | 517.35m | 71.00 | -- | 1.07 | -- | 7.20 | -0.1172 | -0.1172 | 0.1727 | 1.07 | 0.1254 | -0.7943 | 4.78 | 102,484.90 | -8.55 | -9.90 | -9.25 | -10.66 | 129.94 | 119.43 | -68.15 | -88.50 | 3.46 | -- | 0.081 | -- | 1.74 | -10.65 | 45.65 | -- | 24.38 | -- |
| Nanexa AB | 10.58m | -39.06m | 601.56m | 15.00 | -- | 7.50 | -- | 56.88 | -0.2644 | -0.2644 | 0.0694 | 0.4874 | 0.0972 | 24.67 | 1.54 | 813,538.40 | -35.91 | -37.21 | -42.59 | -44.95 | 69.56 | 93.79 | -369.29 | -355.05 | 2.07 | -21.98 | 0.2165 | -- | -16.93 | 70.11 | 67.40 | -- | 21.42 | -- |
| BioPorto A/S | 52.02m | -123.49m | 693.17m | 48.00 | -- | 12.72 | -- | 13.33 | -0.1973 | -0.1973 | 0.083 | 0.0774 | 0.4132 | 2.55 | 4.69 | 962,131.60 | -98.08 | -65.22 | -133.92 | -88.74 | 63.90 | 64.15 | -237.40 | -222.22 | 1.71 | -- | 0.1916 | -- | 17.07 | 6.36 | -21.15 | -- | -20.56 | -- |
| OssDsign AB | 180.16m | -50.99m | 704.69m | 32.00 | -- | 2.27 | -- | 3.91 | -0.5493 | -0.5493 | 2.06 | 2.80 | 0.5109 | 0.3672 | 6.95 | 5,629,938.00 | -14.46 | -25.42 | -16.05 | -28.59 | 96.29 | 85.57 | -28.30 | -82.42 | 6.33 | -13.77 | 0.0044 | -- | 34.51 | 48.59 | -2.68 | -- | 24.28 | -- |
| Senzime AB (publ) | 89.71m | -120.62m | 710.61m | 50.00 | -- | 2.04 | -- | 7.92 | -0.8672 | -0.8672 | 0.6394 | 2.22 | 0.234 | 1.73 | 5.99 | 1,794,120.00 | -31.47 | -35.09 | -34.04 | -37.52 | 41.86 | 8.75 | -134.46 | -400.65 | 4.30 | -7.70 | 0.0399 | -- | 63.55 | 54.18 | 11.50 | -- | 40.12 | -- |
| Omda AS | 442.41m | -28.20m | 804.30m | 260.00 | -- | 25.36 | 29.13 | 1.82 | -1.51 | -1.51 | 23.59 | 1.63 | 0.6793 | 26.59 | 21.70 | 1,772,075.00 | -4.33 | -5.14 | -5.39 | -6.63 | 93.69 | 91.09 | -6.37 | -10.32 | 0.6483 | 0.5281 | 0.9359 | -- | 3.45 | 15.80 | -163.95 | -- | -15.57 | -- |
| Gentian Diagnostics ASA | 160.71m | 39.85m | 821.79m | 63.00 | 20.92 | 4.37 | 17.03 | 5.11 | 2.73 | 2.73 | 11.07 | 13.10 | 0.8181 | 1.63 | 7.83 | 2,738,365.00 | 20.29 | -2.99 | 22.99 | -3.36 | 55.06 | 44.66 | 24.80 | -5.84 | 4.16 | -- | 0.0094 | -- | 12.52 | 25.96 | 525.37 | -- | 22.08 | -- |
| Optomed Oyj | 184.77m | -61.07m | 904.22m | 112.00 | -- | 3.85 | -- | 4.89 | -0.2915 | -0.2915 | 0.8803 | 1.03 | 0.5847 | 2.40 | 5.47 | 151,147.80 | -19.33 | -14.59 | -23.47 | -17.41 | 64.64 | 65.60 | -33.05 | -31.36 | 1.60 | -20.89 | 0.1221 | -- | -0.3974 | 0.084 | -22.72 | -- | 8.10 | -- |
| Nexstim Oyj | 106.99m | -3.01m | 966.15m | 40.00 | -- | 28.47 | 136.93 | 9.03 | -0.042 | -0.042 | 1.47 | 0.4426 | 0.8553 | 0.5613 | 4.66 | 251,616.80 | -2.40 | -12.40 | -4.17 | -20.76 | 94.36 | 95.09 | -2.81 | -16.29 | 1.08 | 0.7835 | 0.6002 | -- | 20.55 | 21.14 | 32.79 | -- | 15.13 | -- |
| Sedana Medical AB (publ) | 197.61m | -40.65m | 990.39m | 117.00 | -- | 1.09 | -- | 5.01 | -0.4092 | -0.4092 | 1.99 | 9.14 | 0.2012 | 1.46 | 9.47 | 2,670,406.00 | -4.14 | -4.90 | -4.34 | -5.16 | 70.47 | 68.32 | -20.57 | -30.26 | 3.28 | -21.90 | 0.0045 | -- | 16.17 | 20.06 | 82.09 | -- | 26.45 | -- |
| ADDvise Group AB (publ) | 1.62bn | 4.30m | 1.04bn | 615.00 | 19.97 | 0.943 | 9.38 | 0.6417 | 0.0864 | 0.0864 | 3.44 | 1.83 | 0.5167 | 7.91 | 4.96 | 2,534,790.00 | 0.1399 | 3.41 | 0.174 | 4.28 | 39.91 | 46.52 | 0.2708 | 6.06 | 0.7562 | 1.62 | 0.5251 | 0.4389 | 21.68 | 36.71 | -13.04 | 85.85 | 52.63 | -- |
Data as of Feb 10 2026. Currency figures normalised to Senzime AB (publ)'s reporting currency: Swedish Krona SEK
22.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 30 Sep 2025 | 8.19m | 5.21% |
| Handelsbanken Fonder ABas of 31 Dec 2024 | 6.19m | 3.94% |
| Unionen (Investment Management)as of 30 Sep 2025 | 6.08m | 3.87% |
| Swedbank Robur Fonder ABas of 30 Dec 2025 | 4.78m | 3.04% |
| Teknik Innovation Norden Fonder ABas of 30 Sep 2025 | 4.52m | 2.87% |
| Wahlstedt & Partners ABas of 31 Dec 2025 | 2.06m | 1.31% |
| Amundi Asset Management SASU (Investment Management)as of 31 Dec 2025 | 1.39m | 0.89% |
| Lannebo Kapitalf�rvaltning AB (Sweden)as of 30 Nov 2025 | 1.06m | 0.67% |
| Storebrand Asset Management ASas of 30 Nov 2025 | 494.20k | 0.31% |
| SEB Funds ABas of 31 Dec 2025 | 448.52k | 0.29% |
More ▼
Data from 30 Sep 2025 - 31 Jan 2026Source: FactSet Research Systems Inc.
